Market Cap 336.55M
Revenue (ttm) 14.56M
Net Income (ttm) -63.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -436.33%
Debt to Equity Ratio 0.00
Volume 724,000
Avg Vol 1,645,608
Day's Range N/A - N/A
Shares Out 249.30M
Stochastic %K 88%
Beta 1.51
Analysts Strong Sell
Price Target $5.14

Company Profile

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally. The company develops OpRegen, an allogeneic retinal pigment epithelium cell replacement therapy, which is in Phase 2a clinical trial for the treatment of the age-related macular degeneration; and OPC1, an allogeneic oligodendrocyte progenitor cell therapy that is in Phase 1/2a multicenter clinical trial for th...

Industry: Biotechnology
Sector: Healthcare
Phone: 442 287 8990
Address:
2173 Salk Avenue, Suite 200, Carlsbad, United States
JP73
JP73 Jul. 4 at 11:41 AM
$LCTX.... 250 years ago our forefathers wrote that great document that gave birth to the GREATEST nation ever. God Bless America. Happy 4th of July! 🇺🇸🇺🇸🇺🇸
0 · Reply
Logic102
Logic102 Jul. 4 at 8:07 AM
$LCTX The Market prices the company as a One Trick Pony and undervalues it even for that one indication. We are an Allogenic Manufacturing Platform. Several Big Pharma companies certainly understand the upside and are very happy with the current share price.
0 · Reply
Trak2
Trak2 Jul. 4 at 4:26 AM
$LCTX everybody have a happy and safe fourth of July! 😁😁🤑🤑🍺🍺
0 · Reply
dannyschell
dannyschell Jul. 4 at 3:58 AM
$LCTX AI is being used in the medical world and I expect it will greatly help people, can LCTX use it or are we past that now? Or will we become irrelevant soon?
0 · Reply
ZiwLexa
ZiwLexa Jul. 3 at 2:30 AM
$LCTX whats our next event folks?
5 · Reply
Logic102
Logic102 Jul. 2 at 1:48 PM
$LCTX Odds of what enfolds over the next 12 months (or sooner, obviously) according to Copilot: My rough, non-investment-opinion probability bands: 30–40% chance Roche acquires LCTX 20–30% chance another pharma makes a move (Lilly, Novo, Vertex, Novartis) 30–40% chance LCTX remains independent but signs multiple partnerships This is unusually high for a small-cap biotech. (My commentary--these odds are NOT currently priced in to the share price, not even close).
9 · Reply
imatisse
imatisse Jul. 2 at 1:47 PM
$LCTX Lineage has grown into one of my 25 hobbies... and the more I delve into it—despite my extremely limited knowledge—the more I get the impression (even with the most pessimistic outlook) that they are sitting on a goldmine. How exactly… that is kept a secret is another story.
2 · Reply
Logic102
Logic102 Jul. 2 at 12:57 PM
$LCTX Here's why I am "big picture" very bullish in a Nutshell. According to MS Copilot: Cell therapy is entering its first true commercial decade — moving from “experimental science” to “repeatable, scalable medicine.” Over the next 5–10 years, cell therapy will expand from niche oncology and transplant support into ophthalmology, diabetes, neurodegeneration, and regenerative medicine. Lineage Cell Therapeutics (LCTX) is positioned unusually well for this shift because it owns a platform for manufacturing specific cell types, not just a single drug. That distinction matters enormously as cell therapy becomes industrialized.
0 · Reply
larrythelooper
larrythelooper Jul. 2 at 5:25 AM
$LCTX 26 years ago LCTX debuted as a $16 stock when all of this was only a Dream…Now that we’re close to the Finish Line, the sky is the Limit! 🚀 Be patient and we will be rewarded mightily!
2 · Reply
qwertylicious2003
qwertylicious2003 Jul. 2 at 2:48 AM
$LCTX https://www.fiercepharma.com/pharma/not-simply-saving-cost-inside-astellas-ceo-5-year-strategy-counter-xtandi-patent-cliff
2 · Reply
Latest News on LCTX
Lineage Cell Therapeutics reports Q1 EPS (3c), consensus (2c)

2026-05-12T22:11:23.000Z - 7 weeks ago

Lineage Cell Therapeutics reports Q1 EPS (3c), consensus (2c)


Lineage Cell Therapeutics Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 7 weeks ago

Lineage Cell Therapeutics Earnings Call Transcript: Q1 2026


Lineage Cell Therapeutics Earnings release: Q1 2026

May 12, 2026, 4:30 PM EDT - 7 weeks ago

Lineage Cell Therapeutics Earnings release: Q1 2026


Lineage Cell Therapeutics Quarterly report: Q1 2026

May 12, 2026, 4:30 PM EDT - 7 weeks ago

Lineage Cell Therapeutics Quarterly report: Q1 2026


Lineage Cell Therapeutics Slides: Corporate presentation

May 12, 2026, 7:00 AM EDT - 7 weeks ago

Lineage Cell Therapeutics Slides: Corporate presentation


Lineage Cell Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

Lineage Cell Therapeutics Proxy statement: Proxy filing


Lineage Cell Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

Lineage Cell Therapeutics Proxy statement: Proxy filing


Lineage Cell Therapeutics initiated with a Buy at Canaccord

2026-04-28T11:14:03.000Z - 2 months ago

Lineage Cell Therapeutics initiated with a Buy at Canaccord


Lineage Announces Formation of Scientific Advisory Board

Apr 13, 2026, 8:00 AM EDT - 2 months ago

Lineage Announces Formation of Scientific Advisory Board


Lineage Cell Therapeutics management to meet with Craig-Hallum

2026-04-08T20:56:34.000Z - 3 months ago

Lineage Cell Therapeutics management to meet with Craig-Hallum


Lineage Cell Therapeutics Slides: Corporate presentation

Mar 25, 2026, 7:00 AM EDT - 3 months ago

Lineage Cell Therapeutics Slides: Corporate presentation


Lineage Cell Therapeutics Earnings Call Transcript: Q4 2025

Mar 5, 2026, 4:30 PM EST - 4 months ago

Lineage Cell Therapeutics Earnings Call Transcript: Q4 2025


Lineage Cell Therapeutics Annual report: Q4 2025

Mar 5, 2026, 4:30 PM EST - 4 months ago

Lineage Cell Therapeutics Annual report: Q4 2025


Lineage Cell Therapeutics Earnings release: Q4 2025

Mar 5, 2026, 4:30 PM EST - 4 months ago

Lineage Cell Therapeutics Earnings release: Q4 2025


Lineage Cell Therapeutics reports Q4 EPS 0c vs (2c) last year

2026-03-05T21:11:09.000Z - 4 months ago

Lineage Cell Therapeutics reports Q4 EPS 0c vs (2c) last year


Lineage Cell Therapeutics management to meet with B, Riley

2026-02-20T14:15:55.000Z - 4 months ago

Lineage Cell Therapeutics management to meet with B, Riley


Lineage Cell Therapeutics Issues Letter to Stockholders

Jan 5, 2026, 8:00 AM EST - 6 months ago

Lineage Cell Therapeutics Issues Letter to Stockholders


Lineage Cell Therapeutics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Lineage Cell Therapeutics Earnings Call Transcript: Q3 2025


Lineage Cell Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Lineage Cell Therapeutics Quarterly report: Q3 2025


Lineage Cell Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Lineage Cell Therapeutics Earnings release: Q3 2025


Lineage Cell Therapeutics reports Q3 EPS (13c), consensus (3c)

2025-11-06T21:12:07.000Z - 8 months ago

Lineage Cell Therapeutics reports Q3 EPS (13c), consensus (3c)


Lineage Cell Therapeutics Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Lineage Cell Therapeutics Earnings Call Transcript: Q2 2025


Lineage Cell Therapeutics Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Lineage Cell Therapeutics Quarterly report: Q2 2025


Lineage Cell Therapeutics Earnings release: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Lineage Cell Therapeutics Earnings release: Q2 2025


Lineage Cell Therapeutics reports Q2 EPS (13c), consensus (3c)

2025-08-12T20:06:19.000Z - 11 months ago

Lineage Cell Therapeutics reports Q2 EPS (13c), consensus (3c)


Lineage Cell Therapeutics doses first patient in DOSED study

2025-08-04T12:12:07.000Z - 11 months ago

Lineage Cell Therapeutics doses first patient in DOSED study


Lineage Cell Therapeutics Proxy statement: Proxy Filing

Jun 11, 2025, 8:00 AM EDT - 1 year ago

Lineage Cell Therapeutics Proxy statement: Proxy Filing


Lineage Cell Therapeutics Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Lineage Cell Therapeutics Earnings Call Transcript: Q1 2025


Lineage Cell Therapeutics Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Lineage Cell Therapeutics Quarterly report: Q1 2025


Lineage Cell Therapeutics Earnings release: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Lineage Cell Therapeutics Earnings release: Q1 2025


Lineage Cell Therapeutics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Lineage Cell Therapeutics Proxy statement: Proxy Filing


Lineage Cell Therapeutics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Lineage Cell Therapeutics Proxy statement: Proxy Filing


Lineage Cell Therapeutics Earnings Call Transcript: Q4 2024

Mar 10, 2025, 4:30 PM EDT - 1 year ago

Lineage Cell Therapeutics Earnings Call Transcript: Q4 2024


Lineage Cell Therapeutics Annual report: Q4 2024

Mar 10, 2025, 4:30 PM EDT - 1 year ago

Lineage Cell Therapeutics Annual report: Q4 2024


Lineage Cell Therapeutics Earnings release: Q4 2024

Mar 10, 2025, 4:30 PM EDT - 1 year ago

Lineage Cell Therapeutics Earnings release: Q4 2024


Lineage Cell Therapeutics Slides: FY 2025

Feb 11, 2025, 12:40 PM EST - 1 year ago

Lineage Cell Therapeutics Slides: FY 2025


Lineage Cell Therapeutics Proxy statement: Proxy Filing

Dec 9, 2024, 7:00 AM EST - 1 year ago

Lineage Cell Therapeutics Proxy statement: Proxy Filing


Lineage Cell Therapeutics Proxy statement: Proxy Filing

Nov 29, 2024, 7:00 AM EST - 1 year ago

Lineage Cell Therapeutics Proxy statement: Proxy Filing


Lineage Cell Therapeutics Earnings Call Transcript: Q3 2024

Nov 14, 2024, 4:30 PM EST - 1 year ago

Lineage Cell Therapeutics Earnings Call Transcript: Q3 2024


Lineage Cell Therapeutics Quarterly report: Q3 2024

Nov 14, 2024, 4:30 PM EST - 1 year ago

Lineage Cell Therapeutics Quarterly report: Q3 2024


Lineage Cell Therapeutics Earnings release: Q3 2024

Nov 14, 2024, 4:30 PM EST - 1 year ago

Lineage Cell Therapeutics Earnings release: Q3 2024


Lineage Cell Therapeutics Earnings Call Transcript: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Lineage Cell Therapeutics Earnings Call Transcript: Q2 2024


Lineage Cell Therapeutics Quarterly report: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Lineage Cell Therapeutics Quarterly report: Q2 2024


Lineage Cell Therapeutics Earnings release: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Lineage Cell Therapeutics Earnings release: Q2 2024


Lineage to Present at 2024 BIO International Convention

May 30, 2024, 8:00 AM EDT - 2 years ago

Lineage to Present at 2024 BIO International Convention


Lineage Cell Therapeutics Earnings Call Transcript: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Lineage Cell Therapeutics Earnings Call Transcript: Q1 2024


Lineage Cell Therapeutics Quarterly report: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Lineage Cell Therapeutics Quarterly report: Q1 2024


Lineage Cell Therapeutics Earnings release: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Lineage Cell Therapeutics Earnings release: Q1 2024


Lineage Announces Changes to Board of Directors

Apr 29, 2024, 4:30 PM EDT - 2 years ago

Lineage Announces Changes to Board of Directors


Lineage Cell Therapeutics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Lineage Cell Therapeutics Proxy statement: Proxy Filing


Lineage Cell Therapeutics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Lineage Cell Therapeutics Proxy statement: Proxy Filing


Lineage Announces Appointment of New Board Member

Apr 23, 2024, 8:05 AM EDT - 2 years ago

Lineage Announces Appointment of New Board Member


JP73
JP73 Jul. 4 at 11:41 AM
$LCTX.... 250 years ago our forefathers wrote that great document that gave birth to the GREATEST nation ever. God Bless America. Happy 4th of July! 🇺🇸🇺🇸🇺🇸
0 · Reply
Logic102
Logic102 Jul. 4 at 8:07 AM
$LCTX The Market prices the company as a One Trick Pony and undervalues it even for that one indication. We are an Allogenic Manufacturing Platform. Several Big Pharma companies certainly understand the upside and are very happy with the current share price.
0 · Reply
Trak2
Trak2 Jul. 4 at 4:26 AM
$LCTX everybody have a happy and safe fourth of July! 😁😁🤑🤑🍺🍺
0 · Reply
dannyschell
dannyschell Jul. 4 at 3:58 AM
$LCTX AI is being used in the medical world and I expect it will greatly help people, can LCTX use it or are we past that now? Or will we become irrelevant soon?
0 · Reply
ZiwLexa
ZiwLexa Jul. 3 at 2:30 AM
$LCTX whats our next event folks?
5 · Reply
Logic102
Logic102 Jul. 2 at 1:48 PM
$LCTX Odds of what enfolds over the next 12 months (or sooner, obviously) according to Copilot: My rough, non-investment-opinion probability bands: 30–40% chance Roche acquires LCTX 20–30% chance another pharma makes a move (Lilly, Novo, Vertex, Novartis) 30–40% chance LCTX remains independent but signs multiple partnerships This is unusually high for a small-cap biotech. (My commentary--these odds are NOT currently priced in to the share price, not even close).
9 · Reply
imatisse
imatisse Jul. 2 at 1:47 PM
$LCTX Lineage has grown into one of my 25 hobbies... and the more I delve into it—despite my extremely limited knowledge—the more I get the impression (even with the most pessimistic outlook) that they are sitting on a goldmine. How exactly… that is kept a secret is another story.
2 · Reply
Logic102
Logic102 Jul. 2 at 12:57 PM
$LCTX Here's why I am "big picture" very bullish in a Nutshell. According to MS Copilot: Cell therapy is entering its first true commercial decade — moving from “experimental science” to “repeatable, scalable medicine.” Over the next 5–10 years, cell therapy will expand from niche oncology and transplant support into ophthalmology, diabetes, neurodegeneration, and regenerative medicine. Lineage Cell Therapeutics (LCTX) is positioned unusually well for this shift because it owns a platform for manufacturing specific cell types, not just a single drug. That distinction matters enormously as cell therapy becomes industrialized.
0 · Reply
larrythelooper
larrythelooper Jul. 2 at 5:25 AM
$LCTX 26 years ago LCTX debuted as a $16 stock when all of this was only a Dream…Now that we’re close to the Finish Line, the sky is the Limit! 🚀 Be patient and we will be rewarded mightily!
2 · Reply
qwertylicious2003
qwertylicious2003 Jul. 2 at 2:48 AM
$LCTX https://www.fiercepharma.com/pharma/not-simply-saving-cost-inside-astellas-ceo-5-year-strategy-counter-xtandi-patent-cliff
2 · Reply
Buyhighsellwhy
Buyhighsellwhy Jul. 1 at 8:13 PM
$LCTX bought more.
2 · Reply
JohnPDaly
JohnPDaly Jul. 1 at 4:04 PM
FDA approves Orca Bio’s cell therapy to improve transplant outcomes $LCTX https://endpoints.news/fda-approves-orca-bios-cell-therapy-to-improve-transplant-outcomes/
1 · Reply
JohnPDaly
JohnPDaly Jul. 1 at 1:19 PM
$LCTX $MDWD $MELI I am having a lousy year. Thesis remains intact. Hopefully we have crossed the Catalyst Desert.🏜️🌵🏜️
3 · Reply
imatisse
imatisse Jul. 1 at 9:30 AM
Yesterday very low Trading volume for Lineage Cell Therapeutics $LCTX stock has reached 865.79K, versus its average volume of 3.38M.
0 · Reply
wblb
wblb Jun. 30 at 7:42 PM
$LCTX Controlling the price is the lack of ANY news in what seems like years and investors relazing Roche is still 6+ months away.
2 · Reply
Tootie
Tootie Jun. 30 at 6:32 PM
$LCTX I think some good news is that if we should happen to get a stock market correction, this stock will go higher. It’s quite obvious shorts control the price here, nothing else.
0 · Reply
alphadog10
alphadog10 Jun. 30 at 6:22 PM
$LCTX Coffee Chat
0 · Reply
JP73
JP73 Jun. 30 at 6:15 PM
$LCTX $XBI XBI continues to roll another 52 week high, traded 160 today. Traded under 80 last year.
0 · Reply
sfoblader
sfoblader Jun. 30 at 4:45 PM
$LCTX Over the last 90 days, LCTX has been locked in a tight range setup with a distinct technical floor: The $1.20 Support Base: Throughout April and May, the stock repeatedly tested an identified support floor near $1.20 to $1.23. Deep dip-buying has reliably stepped in every time the stock reached these lows. Resistance Ceiling: The stock has faced a near-term ceiling at $1.37, which it touched earlier today. A sustained volume push past this point could trigger a "bull flag" breakout toward its 52-week high of $2.09. Current Status: LCTX is currently showing a slow, steady grind higher from its late-spring lows. It is forming higher structural lows, making it look much healthier technically than it did a month ago.
0 · Reply
wblb
wblb Jun. 30 at 2:52 PM
$LCTX " hopefully " we will see something before end 26. Hmmmm. doesn't sound like it's around the next corner. Who else has been saying be prepared to wait.
0 · Reply
Ablidy
Ablidy Jun. 30 at 2:17 PM
$LCTX interesting what Jessie has to say
3 · Reply
JohnPDaly
JohnPDaly Jun. 30 at 2:01 PM
$LCTX Opregen is just Proof of Platform.
0 · Reply